A big store called Macy's is closing some of its shops because they are not making enough money there. They want to focus on making their main shops better. Crude oil, which is a type of fuel, became more expensive and that made the price of things go up a little bit. Some other companies had good news and their stocks went up in value. One company had bad news and its stocks lost half of their value. Read from source...

- The article title is misleading and sensationalized. It implies that crude oil gains are directly related to Macy's store closures, which is not necessarily true or supported by evidence. A more accurate title would be "Crude Oil Gains 1% and Janux Therapeutics Soars; Macy's Plans To Close 150 Stores".
- The article body does not provide any clear connection between crude oil gains and Macy's store closures. It mentions that Macy's sales fell by 1.7% YoY, but does not explain how this affects the demand for crude oil or its price. A possible explanation could be that lower retail sales lead to reduced consumer spending and decreased economic activity, which in turn lowers the demand for energy and crude oil prices. However, this is not explicitly stated or supported by data or analysis.
- The article body focuses too much on the stock performance of Janux Therapeutics, Hims & Hers Health, Viking Therapeutics, and Minerva Neurosciences. These companies are not directly related to the main topics of crude oil gains and Macy's store closures, and their stock fluctuations do not provide any meaningful insights into the underlying causes or consequences of these events. The article would be more informative if it focused on the factors that influence crude oil prices and the challenges faced by retailers in the current market environment.
- The article body uses vague and ambiguous terms to describe the new strategy of Macy's, such as "A Bold New Chapter" and "return the company to enterprise growth". These phrases are not clearly defined or supported by any data or evidence. They also convey a positive spin on the situation, which could be seen as biased or irrational. A more objective and rational approach would be to present the challenges faced by Macy's, the reasons for closing 150 stores, and the expected outcomes of this strategy in terms of cost savings, customer satisfaction, and market share.

1. Janux Therapeutics (NASDAQ:JANX): Buy, high risk, high reward - The company has shown impressive clinical data for its two programs and has a potential breakthrough therapy. However, the stock is highly volatile and subject to regulatory uncertainty.
2. Hims & Hers Health (NYSE:HIMS): Buy, moderate risk, moderate reward - The company has strong financial results and guidance, as well as a diversified product portfolio. However, it faces competition from other telehealth platforms and may face regulatory challenges in some states.
3. Macy's (NYSE:M): Sell, high risk, low reward - The company plans to close 150 stores, which will negatively affect its sales and earnings. It also has a high debt level and faces intense competition from online retailers and other department stores.